Literature DB >> 33744438

LncRNA SNHG6 accelerates nasopharyngeal carcinoma progression via modulating miR-26a-5p/ARPP19 axis.

Xiaodong Yin1, Xilan Gu1, Fenjun Li1, Fei Ye1, Fang Liu1, Wenbin Wang2.   

Abstract

OBJECTIVES: Long noncoding RNAs (lncRNAs) have been reported to be involved in multiple cancer progression, yet the biological role of lncRNA SNHG6 in nasopharyngeal carcinoma (NPC) is still unclear. This research aims to explore the molecular mechanism of SNHG6 in the development and progression of NPC.
DESIGN: Prospective feasibility study.
SETTING: The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital. Long noncoding RNAs (lncRNAs) have been reported to be involved in multiple cancer progression, yet the biological role of lncRNA SNHG6 in nasopharyngeal carcinoma (NPC) is still unclear. This research aims to explore the molecular mechanism of SNHG6 in the development and progression of NPC. RT-qPCR assay was used to examine the expression of SNHG6, miR-26a-5p, and ARPP19 in NPC. CCK-8 and transwell assays were employed to detect NPC cell viability, migration, and invasion. The interaction between miR-26a-5p and SNHG6 or ARPP19 was determined by the luciferase reporter, RIP and RNA pull-down assays. We observed that SNHG6 expression was enhanced in NPC tissues and cells. SNHG6 deletion attenuated NPC cell viability and metastasis. MiR-26a-5p was predicted and validated to interact with SNHG6, and miR-26a-5p expression was markedly elevated in NPC after SNHG6 silence. Moreover, miR-26a-5p inhibitor rescued the suppressive effect of SNHG6 depletion on NPC cell viability, migration and invasion. Besides, ARPP19 was a target of SNHG6 and positively regulated by SNHG6. ARPP19 overexpression neutralized the repressive effect of SNHG6 knockdown on NPC progression. Our results indicated that SNHG6 regulated NPC progression through modulating miR-26a-5/ARPP19 axis, which might provide new insights into NPC diagnosis and treatment.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ARPP19; Nasopharyngeal carcinoma; lncRNA SNHG6; miR-26a-5p

Year:  2021        PMID: 33744438     DOI: 10.1016/j.bmcl.2021.127955

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  miR-26a-5p suppresses nasopharyngeal carcinoma progression by inhibiting PTGS2 expression.

Authors:  Binlin Cai; Xiu Qu; Dan Kan; Yi Luo
Journal:  Cell Cycle       Date:  2022-01-25       Impact factor: 4.534

2.  LINC00240 knockdown inhibits nasopharyngeal carcinoma progress by targeting miR-26a-5p.

Authors:  Xing Chen; Guixiang Wu; Jing Qing; Chunlin Li; Xudong Chen; Jian Shen
Journal:  J Clin Lab Anal       Date:  2022-04-14       Impact factor: 3.124

3.  MiR-26a-5p regulates proliferation, apoptosis, migration and invasion via inhibiting hydroxysteroid dehydrogenase like-2 in cervical cancer cell.

Authors:  Ming Li; Yubo Xiao; Minqi Liu; Qian Ning; Ziye Xiang; Xiang Zheng; Shengsong Tang; Zhongcheng Mo
Journal:  BMC Cancer       Date:  2022-08-10       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.